Copyright Reports & Markets. All rights reserved.

Global Nicotine Gums and Lozenges Market Research Report 2021

Request for Sample of this report
Buy now

1 Nicotine Gums and Lozenges Market Overview

  • 1.1 Product Overview and Scope of Nicotine Gums and Lozenges
  • 1.2 Nicotine Gums and Lozenges Segment by Type
    • 1.2.1 Global Nicotine Gums and Lozenges Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 2 mg/piece
    • 1.2.3 4 mg/piece
    • 1.2.4 Other
  • 1.3 Nicotine Gums and Lozenges Segment by Application
    • 1.3.1 Nicotine Gums and Lozenges Sales Comparison by Application: (2021-2027)
    • 1.3.2 Withdrawal Clinics
    • 1.3.3 Medical Practice
    • 1.3.4 Individual Smokers
    • 1.3.5 Others
  • 1.4 Global Nicotine Gums and Lozenges Market Size Estimates and Forecasts
    • 1.4.1 Global Nicotine Gums and Lozenges Revenue 2016-2027
    • 1.4.2 Global Nicotine Gums and Lozenges Sales 2016-2027
    • 1.4.3 Nicotine Gums and Lozenges Market Size by Region: 2016 Versus 2021 Versus 2027

2 Nicotine Gums and Lozenges Market Competition by Manufacturers

  • 2.1 Global Nicotine Gums and Lozenges Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Nicotine Gums and Lozenges Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Nicotine Gums and Lozenges Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Nicotine Gums and Lozenges Manufacturing Sites, Area Served, Product Type
  • 2.5 Nicotine Gums and Lozenges Market Competitive Situation and Trends
    • 2.5.1 Nicotine Gums and Lozenges Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Nicotine Gums and Lozenges Players Market Share by Revenue
    • 2.5.3 Global Nicotine Gums and Lozenges Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Nicotine Gums and Lozenges Retrospective Market Scenario by Region

  • 3.1 Global Nicotine Gums and Lozenges Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Nicotine Gums and Lozenges Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Nicotine Gums and Lozenges Market Facts & Figures by Country
    • 3.3.1 North America Nicotine Gums and Lozenges Sales by Country
    • 3.3.2 North America Nicotine Gums and Lozenges Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Nicotine Gums and Lozenges Market Facts & Figures by Country
    • 3.4.1 Europe Nicotine Gums and Lozenges Sales by Country
    • 3.4.2 Europe Nicotine Gums and Lozenges Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Nicotine Gums and Lozenges Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Nicotine Gums and Lozenges Sales by Region
    • 3.5.2 Asia Pacific Nicotine Gums and Lozenges Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Nicotine Gums and Lozenges Market Facts & Figures by Country
    • 3.6.1 Latin America Nicotine Gums and Lozenges Sales by Country
    • 3.6.2 Latin America Nicotine Gums and Lozenges Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Nicotine Gums and Lozenges Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Nicotine Gums and Lozenges Sales by Country
    • 3.7.2 Middle East and Africa Nicotine Gums and Lozenges Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Nicotine Gums and Lozenges Historic Market Analysis by Type

  • 4.1 Global Nicotine Gums and Lozenges Sales Market Share by Type (2016-2021)
  • 4.2 Global Nicotine Gums and Lozenges Revenue Market Share by Type (2016-2021)
  • 4.3 Global Nicotine Gums and Lozenges Price by Type (2016-2021)

5 Global Nicotine Gums and Lozenges Historic Market Analysis by Application

  • 5.1 Global Nicotine Gums and Lozenges Sales Market Share by Application (2016-2021)
  • 5.2 Global Nicotine Gums and Lozenges Revenue Market Share by Application (2016-2021)
  • 5.3 Global Nicotine Gums and Lozenges Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Novartis
    • 6.1.1 Novartis Corporation Information
    • 6.1.2 Novartis Description and Business Overview
    • 6.1.3 Novartis Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Novartis Product Portfolio
    • 6.1.5 Novartis Recent Developments/Updates
  • 6.2 Perrigo Company
    • 6.2.1 Perrigo Company Corporation Information
    • 6.2.2 Perrigo Company Description and Business Overview
    • 6.2.3 Perrigo Company Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Perrigo Company Product Portfolio
    • 6.2.5 Perrigo Company Recent Developments/Updates
  • 6.3 Pharmacia
    • 6.3.1 Pharmacia Corporation Information
    • 6.3.2 Pharmacia Description and Business Overview
    • 6.3.3 Pharmacia Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Pharmacia Product Portfolio
    • 6.3.5 Pharmacia Recent Developments/Updates
  • 6.4 Fertin Pharma
    • 6.4.1 Fertin Pharma Corporation Information
    • 6.4.2 Fertin Pharma Description and Business Overview
    • 6.4.3 Fertin Pharma Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Fertin Pharma Product Portfolio
    • 6.4.5 Fertin Pharma Recent Developments/Updates
  • 6.5 Revolymer
    • 6.5.1 Revolymer Corporation Information
    • 6.5.2 Revolymer Description and Business Overview
    • 6.5.3 Revolymer Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Revolymer Product Portfolio
    • 6.5.5 Revolymer Recent Developments/Updates
  • 6.6 Johnson & Johnson
    • 6.6.1 Johnson & Johnson Corporation Information
    • 6.6.2 Johnson & Johnson Description and Business Overview
    • 6.6.3 Johnson & Johnson Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Johnson & Johnson Product Portfolio
    • 6.6.5 Johnson & Johnson Recent Developments/Updates
  • 6.7 Alchem International
    • 6.6.1 Alchem International Corporation Information
    • 6.6.2 Alchem International Description and Business Overview
    • 6.6.3 Alchem International Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Alchem International Product Portfolio
    • 6.7.5 Alchem International Recent Developments/Updates
  • 6.8 Cambrex Corporation
    • 6.8.1 Cambrex Corporation Corporation Information
    • 6.8.2 Cambrex Corporation Description and Business Overview
    • 6.8.3 Cambrex Corporation Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Cambrex Corporation Product Portfolio
    • 6.8.5 Cambrex Corporation Recent Developments/Updates
  • 6.9 GlaxoSmithKline
    • 6.9.1 GlaxoSmithKline Corporation Information
    • 6.9.2 GlaxoSmithKline Description and Business Overview
    • 6.9.3 GlaxoSmithKline Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 GlaxoSmithKline Product Portfolio
    • 6.9.5 GlaxoSmithKline Recent Developments/Updates
  • 6.10 Reynolds American
    • 6.10.1 Reynolds American Corporation Information
    • 6.10.2 Reynolds American Description and Business Overview
    • 6.10.3 Reynolds American Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Reynolds American Product Portfolio
    • 6.10.5 Reynolds American Recent Developments/Updates
  • 6.11 Dr. Reddy's Laboratories
    • 6.11.1 Dr. Reddy's Laboratories Corporation Information
    • 6.11.2 Dr. Reddy's Laboratories Nicotine Gums and Lozenges Description and Business Overview
    • 6.11.3 Dr. Reddy's Laboratories Nicotine Gums and Lozenges Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Dr. Reddy's Laboratories Product Portfolio
    • 6.11.5 Dr. Reddy's Laboratories Recent Developments/Updates

7 Nicotine Gums and Lozenges Manufacturing Cost Analysis

  • 7.1 Nicotine Gums and Lozenges Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Nicotine Gums and Lozenges
  • 7.4 Nicotine Gums and Lozenges Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Nicotine Gums and Lozenges Distributors List
  • 8.3 Nicotine Gums and Lozenges Customers

9 Nicotine Gums and Lozenges Market Dynamics

  • 9.1 Nicotine Gums and Lozenges Industry Trends
  • 9.2 Nicotine Gums and Lozenges Growth Drivers
  • 9.3 Nicotine Gums and Lozenges Market Challenges
  • 9.4 Nicotine Gums and Lozenges Market Restraints

10 Global Market Forecast

  • 10.1 Nicotine Gums and Lozenges Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Nicotine Gums and Lozenges by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Nicotine Gums and Lozenges by Type (2022-2027)
  • 10.2 Nicotine Gums and Lozenges Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Nicotine Gums and Lozenges by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Nicotine Gums and Lozenges by Application (2022-2027)
  • 10.3 Nicotine Gums and Lozenges Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Nicotine Gums and Lozenges by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Nicotine Gums and Lozenges by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    2 mg/piece
    4 mg/piece
    Other

    Segment by Application
    Withdrawal Clinics
    Medical Practice
    Individual Smokers
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Novartis
    Perrigo Company
    Pharmacia
    Fertin Pharma
    Revolymer
    Johnson & Johnson
    Alchem International
    Cambrex Corporation
    GlaxoSmithKline
    Reynolds American
    Dr. Reddy's Laboratories

    Buy now